CD4+ and CD8+ T lymphocytes have been pathologically implicated in patients with demyelination conditions, such as experimental autoimmune encephalomyelitis and multiple sclerosis (Sospedra and Martin, 2005; Wagner et al., 2020). This evidence concerns the gene CD8A and multiple sclerosis.